Explore our range of useful resources, designed to support you with your decision making. You can download the files to refer to later.
For ENTRESTO® (sacubitril/valsartan) prescribing information click here
For Inclisiran▼ (Leqvio®) prescribing information click here
NHS Scotland Heart Failure Transition and Recovery Plan in response to COVID-19 (25th May 2020)
Download the key recommendations from the Heart Failure Hub Scotland to ensure a sustainable model of care for heart failure patients during the COVID-19 pandemic, as we move into the recovery phase of the plan.
CaReMe algorithm for chronic heart failure management
Download the management algorithm for chronic heart failure in adults from CaReMe UK, 2021.
JACC treatment algorithm for guideline-directed medical therapy including novel therapies
Download the treatment algorithm for the management of patients with chronic heart failure with reduced ejection fraction, from the Journal of the American College of Cardiology (JACC).
Bradford Pathway for the Management of Heart Failure with Left Ventricular Systolic Dysfunction (LVSD)
Download the Bradford Pathway for the management of heart failure with LVSD.
NICE Guidance on Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia
Technology appraisal guidance [TA733] from NICE.
This document contains links which will take you to external websites over which Novartis Pharmaceuticals UK Limited has no ownership or control. Novartis Pharmaceuticals UK Limited accepts no responsibility for the content, accuracy, or your use of linked websites.
SMC guidance on the use of Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia
Inclisiran is accepted for restricted use within NHS Scotland in adults with primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, as monotherapy or in combination with lipid-lowering therapies.
This document contains links which will take you to external websites over which Novartis Pharmaceuticals UK Limited has no ownership or control. Novartis Pharmaceuticals UK Limited accepts no responsibility for the content, accuracy, or your use of linked websites.
If you would like to find out more, please search NHS futures.
COVID-19, coronavirus disease 2019; CaReMe, cardio-renal-metabolic; JACC, Journal of the American College of Cardiology (JACC); LVSD, left ventricular systolic dysfunction; NHS, National Health Service; NICE, National Institute for Health and Care Excellence; SMC, Scottish Medicines Consortium.